SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vichien Srimuninnimit, Virote Sriuranpong, Suthida Suwanvecho, Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study, Asia-Pacific Journal of Clinical Oncology, 2014, 10, 3
  2. 2
    Anna Patrikidou, Isabelle Sinapi, Hélène Regnault, Florence Fayard, Mohamed Bouattour, Laetitia Fartoux, Sandrine Faivre, David Malka, Michel Ducreux, Valerie Boige, Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies, Investigational New Drugs, 2014,

    CrossRef

  3. 3
    Andrew J. Page, David C. Cosgrove, Benjamin Philosophe, Timothy M. Pawlik, Hepatocellular Carcinoma, Surgical Oncology Clinics of North America, 2014, 23, 2, 289

    CrossRef

  4. 4
    F. Petrelli, A. Coinu, K. Borgonovo, M. Cabiddu, M. Ghilardi, V. Lonati, S. Barni, Oxaliplatin-based Chemotherapy: A New Option in Advanced Hepatocellular Carcinoma. A Systematic Review and Pooled Analysis, Clinical Oncology, 2014, 26, 8, 488

    CrossRef

  5. 5
    Omar Abdel-Rahman, Revisiting Oxaliplatin-based Regimens for Advanced Hepatocellular Carcinoma, Current Oncology Reports, 2014, 16, 8

    CrossRef

  6. 6
    Alejandro Forner, Marine Gilabert, Jordi Bruix, Jean-Luc Raoul, Treatment of intermediate-stage hepatocellular carcinoma, Nature Reviews Clinical Oncology, 2014, 11, 9, 525

    CrossRef

  7. 7
    Motoyuki Hashiguchi, Shinichi Ueno, Masahiko Sakoda, Satoshi Iino, Kouji Minami, Kei Andou, Yukou Mataki, Kousei Maemura, Hiroyuki Shinchi, Shoji Natsugoe, A Long-term Survivor with Fibrolamellar Hepatocellular Carcinoma Receiving Aggressive Surgery in Combination with Portal Vein Embolization, The Japanese Journal of Gastroenterological Surgery, 2013, 46, 11, 822

    CrossRef

  8. 8
    Rangaswamy Govindarajan, Eric Siegel, Issam Makhoul, Stephen Williamson, Bevacizumab and Erlotinib in Previously Untreated Inoperable and Metastatic Hepatocellular Carcinoma, American Journal of Clinical Oncology, 2013, 36, 3, 254

    CrossRef

  9. 9
    Marion Dhooge, Romain Coriat, Olivier Mir, Géraldine Perkins, Catherine Brezault, Pascaline Boudou-Rouquette, François Goldwasser, Stanislas Chaussade, Feasibility of Gemcitabine plus Oxaliplatin in Advanced Hepatocellular Carcinoma Patients with Child-Pugh B Cirrhosis, Oncology, 2013, 84, 1, 32

    CrossRef

  10. 10
    Aziz Zaanan, Nicolas Williet, Mohamed Hebbar, Tienhan Sandrine Dabakuyo, Laetitia Fartoux, Touraj Mansourbakht, Olivier Dubreuil, Olivier Rosmorduc, Stéphane Cattan, Franck Bonnetain, Valérie Boige, Julien Taïeb, Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study, Journal of Hepatology, 2013, 58, 1, 81

    CrossRef

  11. 11
    Monica Dandona Desai, Bikramajit Singh Saroya, Albert Craig Lockhart, Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers, Expert Opinion on Investigational Drugs, 2013, 22, 3, 341

    CrossRef

  12. 12
    Hung-Hua Liang, Po-Li Wei, Chin-Sheng Hung, Chun-Te Wu, Weu Wang, Ming-Te Huang, Yu-Jia Chang, MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells, Tumor Biology, 2013, 34, 5, 3209

    CrossRef

  13. 13
    Uzma Asghar, Tim Meyer, Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?, Journal of Hepatology, 2012, 56, 3, 686

    CrossRef

  14. 14
    Hua Zhu, Ping Sun, Clinical study of FOLFOX4 regimen for patients of advanced hepatocellular carcinoma, The Chinese-German Journal of Clinical Oncology, 2012, 11, 3, 134

    CrossRef

  15. 15
    Romain Coriat, Olivier Mir, Anatole Cessot, Catherine Brezault, Stanislas Ropert, Jean-Philippe Durand, Wulfran Cacheux, Stanislas Chaussade, François Goldwasser, Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients, Investigational New Drugs, 2012, 30, 1, 376

    CrossRef

  16. 16
    Steven R. Alberts, Joel M. Reid, Bruce W. Morlan, Gist H. Farr, John K. Camoriano, David B. Johnson, James R. Enger, Thomas E. Seay, George P. Kim, Gemcitabine and Docetaxel for Hepatocellular Carcinoma, American Journal of Clinical Oncology, 2012, 35, 5, 418

    CrossRef

  17. 17
    Olivier Mir, Romain Coriat, Pascaline Boudou-Rouquette, Stanislas Ropert, Jean-Philippe Durand, Anatole Cessot, Vincent Mallet, Philippe Sogni, Stanislas Chaussade, Stanislas Pol, François Goldwasser, Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib, Medical Oncology, 2012, 29, 4, 2793

    CrossRef

  18. 18
    Jean-Philippe Spano, Y. Vano, S. Vignot, T. De La Motte Rouge, L. Hassani, R. Mouawad, F. Menegaux, D. Khayat, L. Leenhardt, GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma, Medical Oncology, 2012, 29, 3, 1421

    CrossRef

  19. 19
    C. Verslype, O. Rosmorduc, P. Rougier, Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2012, 23, suppl 7, vii41

    CrossRef

  20. 20
    Chin-Sheng Hung, Shen-Fu Lin, Hui-Hsiung Liu, Li-Jen Kuo, Li-Tzu Li, Hou-Yu Su, Phui-Ly Liew, Feng-Yen Lin, Po-Li Wei, Der-Zen Liu, Yu-Jia Chang, Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma, Annals of Surgical Oncology, 2012, 19, 8, 2744

    CrossRef

  21. 21
    Davendra P. S. Sohal, Weijing Sun, Hepatocellular Carcinoma: Prevention and Therapy, Current Oncology Reports, 2011, 13, 3, 186

    CrossRef

  22. 22
    Giuseppe Lombardi, Fable Zustovich, Fabio Farinati, Umberto Cillo, Alessandro Vitale, Giacomo Zanus, Martin Donach, Miriam Farina, Stefania Zovato, Davide Pastorelli, Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma, Cancer, 2011, 117, 1
  23. 23
    Weijing Sun, Davendra Sohal, Daniel G. Haller, Kristine Mykulowycz, Mark Rosen, Michael C. Soulen, Millie Caparro, Ursina R. Teitelbaum, Bruce Giantonio, Peter J. O'Dwyer, Abraham Shaked, Rajender Reddy, Kim Olthoff, Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma, Cancer, 2011, 117, 14
  24. 24
    P. Merle, F. Mornex, Prise en charge médicale du carcinome hépatocellulaire, Cancer/Radiothérapie, 2011, 15, 1, 28

    CrossRef

  25. 25
    A. K. Elpiner, E. M. Brodsky, T. N. Hazzah, G. S. Post, Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas, Veterinary and Comparative Oncology, 2011, 9, 4
  26. 26
    Stephen H. Wrzesinski, Tamar H. Taddei, Mario Strazzabosco, Systemic Therapy in Hepatocellular Carcinoma, Clinics in Liver Disease, 2011, 15, 2, 423

    CrossRef

  27. 27
    Hye Ryun KIM, Seong Ha CHEON, Sun Young RHA, Soohyeon LEE, Kwang-Hyub HAN, Chae Yoon CHON, Jong Doo LEE, Jin Sil SUNG, Hyun Cheol CHUNG, Treatment of recurrent hepatocellular carcinoma after liver transplantation, Asia-Pacific Journal of Clinical Oncology, 2011, 7, 3
  28. 28
    T. Takahara, H. Nitta, Y. Hasegawa, N. Itou, M. Takahashi, G. Wakabayashi, Using Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation—Interactions Between Calcineurin Inhibitor: Two Case Reports, Transplantation Proceedings, 2011, 43, 7, 2800

    CrossRef

  29. 29
    George Papatsimbas, Christina Chatedaki, Dimitris Zacharoulis, Targeted Therapies for Hepatocellular Carcinoma, 2011,

    CrossRef

  30. 30
    Krisztina Hagymási, Zsolt Tulassay, A májsejtrák célzott kezelésének újabb lehetőségei a molekuláris biológiai adatok ismeretében, Orvosi Hetilap, 2010, 151, 43, 1763

    CrossRef

  31. 31
    Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin, Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, 2010, 4, 2, 439

    CrossRef

  32. You have free access to this content32
    Chapter 4: Chemotherapy and radiotherapy, Hepatology Research, 2010, 40,
  33. 33
    Jacqueline Whang-Peng, Ann-Lii Cheng, Chiun Hsu, Chien-Ming Chen, Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma, Journal of Experimental & Clinical Medicine, 2010, 2, 3, 93

    CrossRef

  34. 34
    Gilles Boschetti, Thomas Walter, Valérie Hervieu, Philippe Cassier, Catherine Lombard-Bohas, Mustapha Adham, Jean-Yves Scoazec, Jérôme Dumortier, Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?, European Journal of Gastroenterology & Hepatology, 2010, 22, 8, 1015

    CrossRef

  35. 35
    Austin Duffy, Tim Greten, Developing better treatments in hepatocellular carcinoma, Expert Review of Gastroenterology & Hepatology, 2010, 4, 5, 551

    CrossRef

  36. 36
    Yu-Yun SHAO, Chun-Chieh HUANG, Po-Chin LIANG, Zhong-Zhe LIN, Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, 2010, 6, 2
  37. 37
    Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber, Hepatocellular Carcinoma: Current Management, Current Problems in Surgery, 2010, 47, 1, 10

    CrossRef

  38. 38
    Ritesh Rathore, Howard Safran, Greg Soares, Greg Dubel, Brendan McNulty, Sun Ahn, David Iannitti, Teresa Kennedy, Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Advanced Hepatocellular Cancer, American Journal of Clinical Oncology, 2010, 33, 1, 43

    CrossRef

  39. 39
    Abby B. Siegel, Sonja K. Olsen, Arthur Magun, Robert S. Brown, Sorafenib: Where do we go from here?, Hepatology, 2010, 52, 1
  40. 40
    Andrew X. Zhu, Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?, Annals of Surgical Oncology, 2010, 17, 5, 1247

    CrossRef

  41. 41
    Lorenza Rimassa, Armando Santoro, The present and the future landscape of treatment of advanced hepatocellular carcinoma, Digestive and Liver Disease, 2010, 42, S273

    CrossRef

  42. 42
    S. Pesque, T. de Baere, V. Boige, Traitements du carcinome hépatocellulaire non accessible à un traitement curatif: actualités, Oncologie, 2010, 12, 10, 615

    CrossRef

  43. 43
    Sung-Chul Lim, Jeong Eun Choi, Ho Sung Kang, Han SI, Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma, International Journal of Cancer, 2010, 126, 7
  44. 44
    Ji Eun Uhm, Joon Oh Park, Jeeyun Lee, Young Suk Park, Se Hoon Park, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Koh, Won Ki Kang, Ho Yeong Lim, A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 63, 5, 929

    CrossRef

  45. 45
    J. O. Lee, K. W. Lee, D. Y. Oh, J. H. Kim, S. A. Im, T. Y. Kim, Y. J. Bang, Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma, Annals of Oncology, 2009, 20, 8, 1402

    CrossRef

  46. 46
    Ju Hyun Shim, Joong-Won Park, Byung Ho Nam, Woo Jin Lee, Chang-Min Kim, Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 63, 3, 459

    CrossRef

  47. 47
    Melanie Thomas, Molecular targeted therapy for hepatocellular carcinoma, Journal of Gastroenterology, 2009, 44, S19, 136

    CrossRef

  48. 48
    Niraj J. Gusani, Yixing Jiang, Eric T. Kimchi, Kevin F. Staveley-OʼCarroll, Hua Cheng, Jaffer A. Ajani, New Pharmacological Developments in the Treatment of Hepatocellular Cancer, Drugs, 2009, 69, 18, 2533

    CrossRef

  49. 49
    Jeong-Ok Lee, Dae-Young Kim, Joo Han Lim, Myung-Deok Seo, Hyeon Gyu Yi, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation, Journal of Gastroenterology and Hepatology, 2009, 24, 5
  50. 50
    Susana Oquiñena, Mercedes Iñarrairaegui, Juan J. Vila, Felix Alegre, Jose M. Zozaya, Bruno Sangro, Spontaneous Regression of Hepatocellular Carcinoma: Three Case Reports and a Categorized Review of the Literature, Digestive Diseases and Sciences, 2009, 54, 5, 1147

    CrossRef

  51. 51
    Won Kim, Jung-Hwan Yoon, Jung-Ryul Kim, In-Jin Jang, Yung-Jue Bang, Yoon-Jun Kim, Hyo-Suk Lee, Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 64, 3, 497

    CrossRef

  52. 52
    Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip, Vascular endothelial growth factor in the management of hepatocellular carcinoma, Cancer, 2009, 115, 21
  53. 53
    Ahmed Kaseb, Melanie Thomas, Hepatocellular Carcinoma, 2009,

    CrossRef

  54. 54
    Mei-Kim Ang, Donald Poon, Kian-Fong Foo, Yaw-Fui Chung, Pierce Chow, Wei-Keat Wan, Choon-Hua Thng, London Ooi, A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma, Hematology/Oncology and Stem Cell Therapy, 2008, 1, 3, 159

    CrossRef

  55. 55
    Amani Asnacios, Laetitia Fartoux, Olivier Romano, Chloe Tesmoingt, Samy Louafi S, Touraj Mansoubakht, Pascal Artru, Thierry Poynard, Olivier Rosmorduc, Mohamed Hebbar, Julien Taieb, Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma, Cancer, 2008, 112, 12
  56. 56
    Natasha Walzer, Laura M Kulik, Hepatocellular carcinoma: latest developments, Current Opinion in Gastroenterology, 2008, 24, 3, 312

    CrossRef

  57. 57
    Ronald Koschny, Carsten Grüllich, Tom Michael Ganten, Standards und neue Aspekte der Diagnostik und Therapie des hepatozellulären Karzinoms, Onkopipeline, 2008, 1, 3, 109

    CrossRef

  58. 58
    L. Costes, M. Ducreux, V. Boige, Traitement systémique du carcinome hépatocellulaire, Oncologie, 2008, 10, 3, 191

    CrossRef

  59. 59
    V Boige, J-L Raoul, J-P Pignon, O Bouché, J-F Blanc, L Dahan, J-L Jouve, N Dupouy, M Ducreux, Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial, British Journal of Cancer, 2007,

    CrossRef

  60. 60
    Daniel H. Palmer, Matthew E. Cramp, Systemic Therapy for Hepatocellular Carcinoma: Future Directions,